Although our research has revealed the strong correlation of abnormal transcript levels of PEMPA1 isoforms (PMEPA1-a and PMEPA1-b) to aggressive prostate cancer outcome, the larger cohort still needs to validate these findings. Here, PMEPA1 is linked to prostate cancer.